Question 1

How much capital is actually flowing into the genomics sector?

Accepted Answer

Global financing for genomics reached US$1.3 billion in 2016, maintaining a consistent three-year trend where annual investment has exceeded the US$1 billion mark. This sustained funding level indicates a maturing market rather than a speculative peak.

Question 2

Which markets are dominating the precision medicine landscape?

Accepted Answer

China is currently outspending the US in state-led initiatives, committing US$9.2 billion to its national precision medicine program. The US counterpart, the All of Us Research Program, is operating with US$215 million in initial funding to aggregate data from 1,000,000 participants.

Question 3

Is private capital moving alongside these government programs?

Accepted Answer

Private investment is actively tracking state initiatives, as seen in WuXi NextCode’s US$75 million Series B round led by Temasek and Yunfeng Capital. Furthermore, the US government recently distributed US$13.8 million to three healthcare provider organizations to accelerate research network expansion.

Question 4

What is being done to ensure the data collected is actually useful for global populations?

Accepted Answer

The US program has allocated US$1.7 million specifically to recruit and engage participants from diverse ethnic and racial backgrounds. This ensures that the genomic databases, which target 1,000,000 total individuals, provide actionable insights across a broad demographic spectrum.

Global landscape: US, China lead race to become DNA superpower

Abstract

Key Takeaways

Frequently Asked Questions

Abstract

Key Takeaways

Frequently Asked Questions

Unlock the full report

Free

Lite

Team